Results 131 to 140 of about 39,364 (153)

Evaluating the updated LATE-NC staging criteria using data from NACC. [PDF]

Alzheimers Dement
Woodworth DC, Nguyen KM, Sordo L, Scambray KA, Head E, Kawas CH, Corrada MM, Nelson PT, Sajjadi SA.   +8 more
europepmc   +1 more source

Prospective Effects of Self-Rated Health on Dementia Risk in Two Twin Studies of Aging. [PDF]

Behav Genet
Pilgrim MJD, Beam CR, Nygaard M, Finkel D.   +3 more
europepmc   +1 more source

The Southern European Atlantic diet and all-cause and cause-specific mortality: a European multicohort study. [PDF]

Eur J Prev Cardiol
Carballo-Casla A, Stefler D, Ortolá R, Chen Y, Knuppel A, Kubinova R, Pajak A, Rodríguez-Artalejo F, Brunner EJ, Bobak M.   +9 more
europepmc   +1 more source

Diverse Fluorescent Probe Concepts for Detection and Monitoring of Reactive Oxygen Species. [PDF]

Chem Asian J
Chaturvedi V, Kumari R, Sharma P, Pati AK.   +3 more
europepmc   +1 more source

Hip Fracture Treatment and Outcomes Among Community-Dwelling People Living With Dementia.

JAMA Netw Open
Adler RR, Xiang L, Shah SK, Clark CJ, Cooper Z, Mitchell SL, Kim DH, Hsu J, Sepucha K, Chunga RE, Lipsitz SR, Weissman JS, Schoenfeld AJ.   +12 more
europepmc   +1 more source

The blood metabolome of cognitive function and brain health in middle-aged adults – influences of genes, gut microbiome, and exposome

Ahmad S, Wu T, Arnold M, Hankemeier T, Ghanbari M, Roshchupkin G, Uitterlinden AG, Neitzel J, Kraaij R, Van Duijn CM, Ikram MA, Kaddurah-Daouk R, Kastenmüller G, the Alzheimer’s Disease Metabolomics Consortium.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A phase I dose-escalation and expansion study of JPI-547, a dual inhibitor of PARP/tankyrase in patients with advanced solid tumors.

Journal of Clinical Oncology, 2021
3113 Background: JPI-547 is an oral inhibitor of PARP 1/2 and Tankyrase 1/2. JPI-547 demonstrated anti-tumor activity in BRCA-deficient xenograft models as a single-agent and in combination with chemotherapy and immune checkpoint inhibitors.
S. Im, Seung Hwan Lee, Keun-Wook Lee, Youngjoo Lee, J. Sohn, J. Kim, Y. Im, K. Park, D. Oh, Min Hwan Kim, Yeon-Hee Park, T. Kim, Y. Choi, Changsuk Lee, Jiseon Park, N. Baek, Mikyung Choi, John Kim, E. Yu, Y. Bang   +19 more
semanticscholar   +1 more source

Characterization of the novel HLA‐B*15:547 allele by next‐generation sequencing

HLA, 2020
B*15:547 differs from B*15:01:01:04 by one nucleotide substitution at position 1051 in exon 7.
Steve Genebrier, V. Elsermans, Carl Nivet, M. Chérel, V. Renac   +4 more
semanticscholar   +1 more source

Mechanism of Translation Termination: RF1 Dissociation Follows Dissociation of RF3 from the Ribosome.

Biochemistry, 2016
Release factors 1 and 2 (RF1 and RF2, respectively) bind to ribosomes that have a stop codon in the A site and catalyze the release of the newly synthesized protein.
Xinying Shi, S. Joseph
semanticscholar   +1 more source